Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma

Life Sciences

Volumn 82, Issue 13-14, 2008, Pages 797-805

  Jung, Won Kyo ^a,b   Lee, Da Young ^a   Choi, Yung Hyun ^c   Yea, Sung Su ^d   Choi, Inhak ^a   Park, Sae Gwang ^a   Seo, Su Kil ^a   Lee, Soo Woong ^a   Lee, Chang Min ^e   Kim, Se kwon ^b   Jeon, You Jin ^f   Choi, Il Whan ^a  

^a Department of Microbiology   (South Korea)

^b Pukyong National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

^f Jeju National University   (South Korea)

Author keywords

Airway hyperresponsiveness; Asthma; Caffeic acid phenethyl ester; Nuclear factor B; Reactive oxygen species

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; EOSINOPHIL; FEMALE; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CAFFEIC ACIDS; CELL COUNT; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; LUNG; MICE; MICE, INBRED BALB C; NF-KAPPA B; OVALBUMIN; PEROXIDES; PHENYLETHYL ALCOHOL; RESPIRATORY HYPERSENSITIVITY;

MURINAE; MUS;

EID: 40649123732     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.01.014     Document Type: Article

References (51)

1. Baldwin Jr. A.S. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14 (1996) 649-683
2. Barnes P.J. Cytokines as mediators of chronic asthma. American Journal of Respiratory and Critical Care Medicine 150 (1994) 42-49
3. Barnes P.J. Nuclear factor-kappa B. International Journal of Biochemistry & Cell Biology 29 (1997) 867-870
4. Barnes P.J. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine & Growth Factor Reviews 14 (2003) 511-522
5. Barnes P.J., and Adcock I.M. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends in Pharmacological Sciences 18 (1997) 46-50
6. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine 336 (1997) 1066-1071
7. Barnes P.J., and Adock I.A. Transcription factors and asthma. European Respiratory Journal 12 (1998) 221-234
8. Blackwell T.S., and Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 17 (1997) 3-9
9. Bowler R.P., and Crapo J.D. Oxidative stress in allergic respiratory diseases. Journal of Allergy and Clinical Immunology. 110 (2002) 349-356
10. Burrows B. Allergy and the development of asthma and bronchial hyperresponsiveness. Clinical and Experimental Allergy 25 (1995) 15-16
11. Burrows B., Martinez F.D., Halonen M., Baebee R.A., and Cline M.G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. The New England Journal of Medicine 320 (1989) 271-277
12. Chan W.S., Wen P.C., and Chiang H.C. Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Research 15 (1995) 703-707
13. Choi I.W., Kim D.K., Ko H.M., and Lee H.K. Administration of antisense hosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice. International Immunopharmacology 4 (2004) 1817-1828
14. Chvatchko Y., Proudfoot A.E., Buser R., Juillard P., Alouani S., Kosco-Vilbois M., Coyle A.J., Nibbs R.J., Graham G., Offord R.E., and Wells T.N. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. Journal of Immunology 171 (2003) 5498-5506
15. Cortijo J., Marti-Cabrera M., de la Asuncion J.G., Pallardo F.V., Esteras A., Bruseghini L., Vina J., and Morcillo E.J. Contraction of human airways by oxidative stress protection by N-acetylcysteine. Free Radical Biology & Medicine 27 (1999) 392-400
16. Dworski R. Oxidant stress in asthma. Thorax 55 (2000) S51-S53
17. Elsner J., Petering H., Kluthe C., Kimmig D., Smolarski R., Ponath P., and Kapp A. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. European Journal of Immunology 28 (1998) 2152-2158
18. Fesen M.R., Kohn K.W., Leteurtre F., and Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 2399-2403
19. Gilmore T.D. The Rel/NF-kappa B signal transduction pathway: introduction. Oncogene 18 (1999) 6842-6844
20. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., and Gelfand E.R. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. American Journal of Respiratory and Critical Care Medicine 156 (1997) 766-775
21. Henderson Jr. W.R., Chi E.Y., Teo J.L., Nguyen C., and Kahn M. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. Journal of Immunology 169 (2002) 5294-5299
22. Hepsen I.F., Er H., and Cekic O. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Research 31 (1999) 426-431
23. Hishikawa K., Nakaki T., and Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005) 442-446
24. Hulsmann A.R., Raatgeep H.R., den Hollander J.C., Stijnen T., Saxena P.R., Kerrebijn K.F., and de Jongste J.C. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. American Journal of Respiratory and Critical Care Medicine 149 (1994) 519-525
25. Ilhan A., Iraz M., Gurel A., Armutcu F., and Akyol O. Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochemical Research 29 (2004) 2287-2292
26. Kim Y.S., Kwon K.S., Kim D.K., Choi I.W., and Lee H.K. Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology 112 (2004) 624-630
27. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., and Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochimica et Biophysica Acta 792 (1984) 92-97
28. Kuo H.C., Kuo W.H., Lee Y.J., Lin W.L., Chou F.P., and Tseng T.H. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Letters 234 (2006) 199-208
29. Kwak Y.G., Song C.H., Yi H.K., Hwang P.H., Kim J.S., Lee K.S., and Lee Y.C. Involvement of PTEN in airway hyper-responsiveness and inflammation in bronchial asthma. The Journal of Clinical Investigation 111 (2003) 1083-1092
30. Lee Y.C., Kwak Y.G., and Song C.H. Contribution of vascular endothelial growth factor to airway hyper-responsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. Journal of Immunology 168 (2002) 3595-3600
31. Lee Y.C., Lee K.S., Park S.J., Park H.S., Lim J.S., Park K.H., Im M.J., Choi I.W., Lee H.K., and Kim U.H. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, l-2-oxothiazolidine-4-carboxylic acid. The FASEB Journal 18 (2004) 1917-1919
32. Liao H.F., Chen Y.Y., Liu J.J., Hsu M.L., Shieh H.J., Liao H.J., Shieh C.J., Shiao M.S., and Chen Y.J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. Journal of Agricultural and Food Chemistry 51 (2003) 7907-7912
33. Michaluart P., Masferrer J.L., Carothers A.M., Subbaramaiah K., Zweifel B.S., Koboldt C., Mestre J.R., Grunberger D., Sacks P.G., Tanabe T., and Dannenberg A.J. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Research 59 (1999) 2347-2352
34. Mirzoeva O.K., Yaqoob P., Knox K.A., and Calder P.C. Inhibition of ICE family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis. FEBS Letters 396 (1996) 266-270
35. Mori A., Kaminuma O., Mikami T., Inoue S., Okumura Y., Akiyama K., and Okudaira H. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. The Journal of Allergy and Clinical Immunology 103 (1999) 429-436
36. Natarajan K., Singh S., Burke Jr. T.R., Grunberger D., and Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 9090-9095
37. Nishida S., Teramoto K., Kimoto-Kinoshita S., Tohda Y., Nakajima S., Tomura T.T., and Irimajiri K. Change of Cu, Zn-superoxide dismutase activity of guinea pig lung in experimental asthma. Free Radical Research 36 (2002) 601-606
38. Ohno H., Tsunemine S., Isa Y., Shimakawa M., and Yamamura H. Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biological & Pharmaceutical Bulletin 28 (2005) 1462-1466
39. Orban Z., Mitsiades N., Burke Jr. T.R., Tsokos M., and Chrousos G.P. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation 7 (2000) 99-105
40. Orsolic N., Terzic S., Mihaljevic Z., Sver L., and Basic I. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biological & Pharmaceutical Bulletin 28 (2005) 1928-1933
41. Park E.H., and Kang J.H. Suppressive effects of propolis in rat adjuvant arthritis. Archives of Pharmacal Research 22 (1999) 554-558
42. Park S.G., Lee D.Y., Seo S.K., Lee S.W., Kim S.K., Jung W.K., Kang M.S., Choi Y.H., Yea S.S., Choi I., and Choi I.W. Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis. Toxicology and Applied Pharmacology 226 (2008) 22-29
43. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. Journal of Biochemistry and Molecular Biology 36 (2003) 95-109
44. Stutz A.M., and Woisetschlager M. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. Journal of Immunology 163 (1999) 4383-4391
45. 2 for platelet-derived growth factor signal transduction. Science (Washington, DC) 270 (1995) 296-299
46. Talati M., Meyrick B., Peebles Jr. R.S., Davies S.S., Dworski R., Mernaugh R., Mitchell D., Boothby M., Roberts II L.J., and Sheller J.R. Oxidant stress modulates murine allergic airway responses. Free Radical Biology and Medicine 40 (2006) 1210-1219
47. Wei X., Zhao L., Ma Z., Holtzman D.M., Yan C., Dodel R.C., Hampel H., Oertel W., Farlow M.R., and Du Y. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 127 (2004) 2629-2635
48. Woerly G., Loiseau S., Loyens M., Schoch C., and Capron M. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Allergy 58 (2003) 397-406
49. Wulczyn F.G., Krappmann D., and Scheidereit C. The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation. Journal of Molecular Medicine 74 (1996) 749-769
50. Zhang M., Nomura A., Uchida Y., Iijima H., Sakamoto T., Iishii Y., Morishima Y., Mochizuki M., Masuyama K., Hirano K., and Sekizawa K. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radical Biology & Medicine 32 (2002) 454-464
51. Zhou L.F., Zhu Y., Cui X.F., Xie W.P., Hu A.H., and Yin K.S. Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation. Respiratory research 7 (2006) 146